RHY 0.00% 11.5¢ rhythm biosciences limited

@Davisite Apologies if I appeared haste to jump down your...

  1. 8,280 Posts.
    lightbulb Created with Sketch. 358
    @Davisite

    Apologies if I appeared haste to jump down your throat, however I feel you're just cherry picking info.

    Yes, it appears they're intending to spend 1.98m this Qtr.

    However what you failed to mention (intentionally or unintentionally - I'm not casting an aspersion either way) is that $1.35m of that spend this Qtr is on R&D.

    AND... they will get 43% of the R&D spend back by way of a cash rebate via the ATO.

    So - net net - they're going to spend 1.3m this Qtr

    They started the Qtr with 7m, less 1.3m spend equals $5.7m. Then we add the $300k they received this Qtr from a R&D rebate - they should finish the Qtr with $6m cash

    All I'm saying is that they launched the IPO last year with the intention to be fully funded to take the product to market & they are on track to achieve that goal.

    2019 is the year of delivery.
    Last edited by Wise_One: 15/12/18
 
watchlist Created with Sketch. Add RHY (ASX) to my watchlist
(20min delay)
Last
11.5¢
Change
0.000(0.00%)
Mkt cap ! $15.41M
Open High Low Value Volume
0.0¢ 0.0¢ 0.0¢ $0 0

Buyers (Bids)

No. Vol. Price($)
1 5969 13.0¢
 

Sellers (Offers)

Price($) Vol. No.
11.0¢ 5500 1
View Market Depth
Last trade - 16.16pm 18/11/2024 (20 minute delay) ?
RHY (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.